Research on Surgical Treatment for Ovarian Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 33
Special Issue Editors
Interests: cancers; surgery
Special Issue Information
Dear Colleagues,
The treatment of ovarian cancer is a challenge. Despite cytoreductive surgery (CRS) with standard peritonectomy procedures followed by systemic chemotherapy, the majority of patients develop recurrence. The integration of hyperthermic intraperitoneal chemotherapy (HIPEC) to CRS has shown that survival in secondary and interval cytoreduction is improved with acceptable morbidity and low in-hospital mortality. There is much evidence that HIPEC is beneficial as an upfront treatment. The effect of HIPEC and novel systemic therapy (PARPi) remains to be established.
The main objective of the issue “Current opinions of ovarian cancer surgical treatment” is to show that CRS plus HIPEC has revolutionized the treatment of ovarian cancer and will help physicians understand that this modern treatment is successfully performed in specialized centers.
Dr. Antonios Apostolos K. Tentes
Prof. Dr. Theo Panoskaltsis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- surgical
- cancer treatment
